» Articles » PMID: 26987995

Bone Material Properties in Osteogenesis Imperfecta

Overview
Date 2016 Mar 19
PMID 26987995
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Osteogenesis imperfecta entrains changes at every level in bone tissue, from the disorganization of the collagen molecules and mineral platelets within and between collagen fibrils to the macroarchitecture of the whole skeleton. Investigations using an array of sophisticated instruments at multiple scale levels have now determined many aspects of the effect of the disease on the material properties of bone tissue. The brittle nature of bone in osteogenesis imperfecta reflects both increased bone mineralization density-the quantity of mineral in relation to the quantity of matrix within a specific bone volume-and altered matrix-matrix and matrix mineral interactions. Contributions to fracture resistance at multiple scale lengths are discussed, comparing normal and brittle bone. Integrating the available information provides both a better understanding of the effect of current approaches to treatment-largely improved architecture and possibly some macroscale toughening-and indicates potential opportunities for alternative strategies that can influence fracture resistance at longer-length scales.

Citing Articles

TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta.

Liu J, Zhang Y, Yu W, Sun L, Hu J, Jiang Y Osteoporos Int. 2025; .

PMID: 39994027 DOI: 10.1007/s00198-025-07423-2.


Improvement of bone properties in children with osteogenesis imperfecta after pamidronate: a bone biopsy study.

Farlay D, Cornier M, Rizzo S, Cormier-Daire V, Charpie M, Pinto G JBMR Plus. 2025; 9(2):ziae161.

PMID: 39822213 PMC: 11736749. DOI: 10.1093/jbmrpl/ziae161.


Family-based whole-exome sequencing implicates a variant in lysyl oxidase like 4 in atypical femur fractures.

Zhou W, van de Laarschot D, van Rooij J, Koedam M, Nguyen H, Uitterlinden A J Bone Miner Res. 2024; 40(1):69-78.

PMID: 39485938 PMC: 11700580. DOI: 10.1093/jbmr/zjae175.


Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.

Misof B, Fratzl-Zelman N Calcif Tissue Int. 2024; 115(6):777-804.

PMID: 39231826 DOI: 10.1007/s00223-024-01263-8.


Regulation of bone homeostasis: signaling pathways and therapeutic targets.

Wu Z, Li W, Jiang K, Lin Z, Qian C, Wu M MedComm (2020). 2024; 5(8):e657.

PMID: 39049966 PMC: 11266958. DOI: 10.1002/mco2.657.